Tapioca (Antigen Laboratories, Inc.)


Welcome to the PulseAid listing for the Tapioca drug offered from Antigen Laboratories, Inc.. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Antigen Laboratories, Inc.
NON-PROPRIETARY NAME: Tapioca
SUBSTANCE NAME: STARCH, TAPIOCA
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS:
ROUTE: INTRADERMAL; SUBCUTANEOUS
DOSAGE FORM: INJECTION, SOLUTION
MARKETING CATEGORY NAME: BLA
START MARKETING DATE: 1974-03-23
END MARKETING DATE: 0000-00-00


Tapioca HUMAN PRESCRIPTION DRUG Details:

Item DescriptionTapioca from Antigen Laboratories, Inc.
LABELER NAME: Antigen Laboratories, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 0.05(g/mL)
START MARKETING DATE: 1974-03-23
END MARKETING DATE: 0000-00-00
PRODUCT ID: 49288-0566_1d11d7ba-8b48-401c-a02e-42b54abb4296
PRODUCT NDC: 49288-0566
APPLICATION NUMBER: BLA102223

Other STARCH, TAPIOCA Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Antigen Laboratories, Inc.Tapioca